A gluten-free diet (GFD) is often the corner pin of many of our recommendations to our Clients. We’ve all heard of its potential value and necessity. And how quickly people ‘feel better’ on a GFD. But what is not commonly known is the increase in mortality with a GFD. Although symptomatic relief is often obtained in a startling number of conditions, the long-term impact of GFDs can be devastating. There is an 86% increased risk of death from a cardiovascular incident in the first year after a client is diagnosed with celiac disease. And 3.78- fold increased risk of mortality from malignancy in the first year after celiac diagnosis. i. Further, comorbidities with wheat related disorders are high. Twentynine (29%) of those with non- celiac wheat sensitivity (NCWS) demonstrate elevated antinuclear antibodies. ii. Within 3 years, 87% of those who were originally aymptomtomatic with elevated ANA antibodies have been diagnosed
with an autoimmune disease. iii. Why is this happening and what can be done about it? Take-away? The Gluten-free Diet is the prerequisite in Wheat Related Disorders. It is not the treatment. We will address this unrecognized adverse reaction, it’s causes and mechanisms and treatment protocols guiding our clients who need to be gluten-free to a vibrant, healthy gluten-free lifestyle.

And with proper preparation, the good news is how easy it can be to guide our patients into balanced gluten-free diets that eliminate these increased unwanted health dangers, enhance health, reduce inflammation and improve quality of life iv.

Objectives:

• Developing a more comprehensive overview of wheat-related disorders
• Successfully and comprehensively identifying wheat-related disorders
• Understanding the causes of increased mortality after diagnosis
• Recognizing the frequency of detrimental impact on the epithelial
lining of the GI Tract with a wheat-related disorder
• Protocols successfully addressing the damage to the intestinal lining
• Recognizing the need for comprehensive dietary guidance for food selections (and avoidances)

References:

i Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F., Small-intestinal histopathology
and mortality risk in celiac disease. JAMA. 2009 Sep 16;302(11):1171-8
ii Carroccio A, Alcamo A, Cavataio F, Soresi M, Seidita A, Sciumè C, Geraci G, Iacono G,
Mansueto P., High Proportions of people with Nonceliac Wheat Sensitivity have Autoimmune
Disease or Antinuclear Antibodies, Gastroenterology. 2015 Sep;149(3):596-603
iii Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies. Pérez D,
Gilburd B, Cabrera-Marante Ó, Martínez-Flores JA, Serrano M, Naranjo L, Pleguezuelo D,
Morillas L, Shovman O, Paz-Artal E, Shoenfeld Y, Serrano A. Clin Chem Lab Med. 2017 Jun 17.
iv Barratt SM, Leeds JS, Sanders DS. Quality of life in coeliac disease is determined by perceived
degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately
achieved. J Gastrointestin Liver Dis. 2011 Sep;20(3):241-5